EZH2 and endometrial cancer: In 11 endometrial cancer cell lines and 52 clinical endometrial cancer specimens, EZH2 mRNA (RT-qPCR) was shown to be significantly overexpressed in cancer cells and tissue compared with the corresponding normal control cell lines and tissue.